Development of Cannabis-Based Treatment for Bipolar Disorder

Bipolar disorder and the endocannabinoid system

A recently published article serves as a call for research to be conducted to discover how cannabis could impact the management of bipolar disorder (BD). Presented in the article is a full review of the advantages and disadvantages of cannabis-based medicine in the treatment of BD and provides insight into possible mechanisms might affect the pathophysiology of the disorder. The insights listed within the article provide the rationale for examining the endocannabinoid system, specifically the cannabinoid receptor 2, with the hopes of finding therapeutic targets for mood control associated with BD.  

View this review (yellow link) or download:

This paper is also stored here:      inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDDevelopment of Cannabis-Based Treatment for Bipolar Disorder

Related Posts